Show Notes
Podcast Description:
Navigating the complexities of systemic anticancer therapy (SACT) demands meticulous attention to detail, especially when it comes to prescribing. In this episode of the Irish Haematology Oncology Podcast, join your host Eoin Tabb as he delves into the critical aspects of safe prescribing practices for SACT. We'll explore the reasons why SACT prescribing is considered high-risk, the essential steps involved in the prescribing process for both first and subsequent cycles, and the key components of a comprehensive treatment plan. We'll also discuss the legal requirements and prescribing standards, strategies to mitigate errors, and the unique safety challenges associated with oral anticancer medicines (OAMs). Whether you're at the beginning of your career or seeking a refresher, this episode will equip you with the knowledge and insights to ensure the safe and effective administration of these powerful medications to your patients.
Takeaways
DPYD testing is crucial for personalized cancer treatment.
SACT medications have a narrow therapeutic index.
Creating a treatment plan requires meaningful patient conversations.
Clear communication among healthcare professionals is essential.
Legal standards in prescribing protect patients and prescribers.
Ambiguity in prescriptions can lead to serious errors.
Pharmacists play a critical role in patient safety.
Oral anti-cancer medicines come with unique safety challenges.
Regular reassessment of patient fitness for treatment is necessary.
Safe prescribing is a shared responsibility among all healthcare providers.
Feedback Form
IIOP Example CPD for Pharmacists
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: